Stephen R. Marder
Building 210
Room 130
West Los Angeles VA Healthcare Center
11301 Wilshire Blvd
USA
Name/email consistency: high
- Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation. Marder, S.R., Sorsaburu, S., Dunayevich, E., Karagianis, J.L., Dawe, I.C., Falk, D.M., Dellva, M.A., Carlson, J.L., Cavazzoni, P.A., Baker, R.W. J. Clin. Psychiatry (2010)
- Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study. Marder, S.R., Kramer, M., Ford, L., Eerdekens, E., Lim, P., Eerdekens, M., Lowy, A. Biol. Psychiatry (2007)
- Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials. Marder, S.R., West, B., Lau, G.S., Pultz, J.A., Pikalov, A., Marcus, R.N., Gutierrez-Esteinou, R., Crandall, D.T. J. Clin. Psychiatry (2007)
- The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia. Marder, S.R. Dialogues. Clinical. Neuroscience (2006)
- Drug initiatives to improve cognitive function. Marder, S.R. J. Clin. Psychiatry (2006)
- Subjective experiences on antipsychotic medications: synthesis and conclusions. Marder, S.R. Acta. Psychiatr. Scand. Suppl (2005)
- Physical health monitoring of patients with schizophrenia. Marder, S.R., Essock, S.M., Miller, A.L., Buchanan, R.W., Casey, D.E., Davis, J.M., Kane, J.M., Lieberman, J.A., Schooler, N.R., Covell, N., Stroup, S., Weissman, E.M., Wirshing, D.A., Hall, C.S., Pogach, L., Pi-Sunyer, X., Bigger, J.T., Friedman, A., Kleinberg, D., Yevich, S.J., Davis, B., Shon, S. Am. J. Psychiatry (2004)
- Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Marder, S.R., Fenton, W. Schizophr. Res. (2004)
- Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Marder, S.R., McQuade, R.D., Stock, E., Kaplita, S., Marcus, R., Safferman, A.Z., Saha, A., Ali, M., Iwamoto, T. Schizophr. Res. (2003)
- Overview of partial compliance. Marder, S.R. J. Clin. Psychiatry (2003)
- Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate. Marder, S.R., Aravagiri, M., Wirshing, W.C., Wirshing, D.A., Lebell, M., Mintz, J. Schizophr. Res. (2002)
- Can clinical practice guide a research agenda?. Marder, S.R. Schizophr. Bull (2002)
- The Mount Sinai conference on the pharmacotherapy of schizophrenia. Marder, S.R., Essock, S.M., Miller, A.L., Buchanan, R.W., Davis, J.M., Kane, J.M., Lieberman, J., Schooler, N.R. Schizophr. Bull (2002)
- Antipsychotic drugs and relapse prevention. Marder, S.R. Schizophr. Res. (1999)
- Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. Marder, S.R., Wirshing, W.C., Mintz, J., McKenzie, J., Johnston, K., Eckman, T.A., Lebell, M., Zimmerman, K., Liberman, R.P. Am. J. Psychiatry (1996)